News
June 16, 2025
AbTherx and GPCR Therapeutics Announce a Strategic Collaboration to Discover...
Partnership combines AbTherx’s proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics’ deep expertise in GPCR biology to discover and develop antibodies for n... Read More »
June 10, 2025
AbTherx and Wield Therapeutics Partner to Advance New Antibody Therapies
AbTherx’s highly efficient research planning and partnering process enabled Wield, an early-stage startup, to achieve concept-to-collaboration within weeks Mountain V... Read More »
May 13, 2025
AbTherx, Single Cell Technology, and Vaccinex Announce Collaboration to Tackle...
AbTherx and Single Cell Technology incorporate ActivMAb® Technology into Atlas™ Mouse and AbTheneum™ antibody discovery platforms Mountain View, Calif. – May 13, 2025... Read More »
May 12, 2025
AbTherx and Spice Biotechnologies Announce Multi-Program Antibody Discovery Collaboration
Immuno-oncology pioneer partners with AbTherx to build the next generation of immunotherapy drugs Mountain View, Calif. – May 12, 2025 – AbTherx, Inc., a biotechnolog... Read More »
April 23, 2025
AbTherx and Rondo Therapeutics Announce Multi-Program Antibody Discovery Collaboration
Partnership leverages AbTherx’s Atlas™ Binary Fixed Light Chain Mouse to accelerate Rondo’s pipeline of bispecific antibodies Mountain View, Calif. – April 23, 2025 –... Read More »
